GE HealthCare Technologies Inc. (NASDAQ:GEHC) Given Consensus Rating of “Moderate Buy” by Analysts

GE HealthCare Technologies Inc. (NASDAQ:GEHC) has earned an average recommendation of “Moderate Buy” from the twelve brokerages that are covering the firm, Marketbeat reports. Six research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $87.0909.

Several research analysts have issued reports on GEHC shares. Citigroup lifted their target price on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Evercore ISI boosted their price objective on shares of GE HealthCare Technologies from $88.00 to $92.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Morgan Stanley lifted their target price on GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a report on Thursday, October 30th. Finally, Stifel Nicolaus set a $90.00 price target on GE HealthCare Technologies in a report on Friday, November 21st.

GE HealthCare Technologies Price Performance

Shares of GE HealthCare Technologies stock opened at $82.52 on Friday. The firm has a market cap of $37.59 billion, a PE ratio of 17.05, a price-to-earnings-growth ratio of 3.44 and a beta of 1.10. GE HealthCare Technologies has a 12-month low of $57.65 and a 12-month high of $94.80. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The company’s fifty day simple moving average is $77.45 and its two-hundred day simple moving average is $75.30.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.05 by $0.02. The firm had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.GE HealthCare Technologies’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. As a group, equities analysts expect that GE HealthCare Technologies will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be paid a dividend of $0.035 per share. The ex-dividend date is Friday, January 9th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 2.89%.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in GEHC. Lineweaver Wealth Advisors LLC purchased a new stake in GE HealthCare Technologies in the second quarter worth about $592,000. National Bank of Canada FI raised its holdings in shares of GE HealthCare Technologies by 133.3% in the 2nd quarter. National Bank of Canada FI now owns 899,693 shares of the company’s stock valued at $66,640,000 after purchasing an additional 514,007 shares in the last quarter. Frontier Capital Management Co. LLC raised its holdings in shares of GE HealthCare Technologies by 5.2% in the 2nd quarter. Frontier Capital Management Co. LLC now owns 356,954 shares of the company’s stock valued at $26,440,000 after purchasing an additional 17,603 shares in the last quarter. Guggenheim Capital LLC lifted its position in shares of GE HealthCare Technologies by 22.3% in the 2nd quarter. Guggenheim Capital LLC now owns 131,985 shares of the company’s stock worth $9,776,000 after purchasing an additional 24,087 shares during the period. Finally, Exome Asset Management LLC bought a new position in shares of GE HealthCare Technologies during the first quarter valued at approximately $2,050,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.